Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnosis and Management of Hereditary Phaeochromocytoma and Paraganglioma.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer - 1 Jan 2016

Lalloo Fiona

Abstract excerpt

About 30% of phaeochromocytomas or paragangliomas are genetic. Whilst some individuals will have clinical features or a family history of inherited cancer syndrome such as neurofibromatosis type 1 (NF1) or multiple endocrine neoplasia 2 (MEN2), the majority will present as an isolated case. To date, 14 genes have been described in which pathogenic mutations have been demonstrated to cause paraganglioma or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Gland Neoplasms
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Neoplastic Syndromes, Hereditary

Share to Paraganglioma

Share to Pheochromocytoma

Source

Identifiers

PMID: 27075351
DOI: 10.1007/978-3-319-29998-3_7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnosis and Management of Hereditary Phaeochromocytoma and Paraganglioma.PMID 27075351Read ↗

When should genetic testing be obtained in a patient with phaeochromocytoma or paraganglioma?Semantic proximity Read ↗

The clinical genetics of phaeochromocytoma and paragangliomaSemantic proximity Read ↗

Phaeochromocytoma and paraganglioma: next-generation sequencing and evolving Mendelian syndromes.Semantic proximity Read ↗

Inherited Mutations in Pheochromocytoma and Paraganglioma: Why All Patients Should Be Offered Genetic TestingSemantic proximity Read ↗

Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas.Semantic proximity Read ↗

Paraganglioma and phaeochromocytoma: from genetics to personalized medicineSemantic proximity Read ↗

Clinical and molecular markers guide the genetics of pheochromocytoma and paraganglioma.Semantic proximity Read ↗

Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statementSemantic proximity Read ↗

Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research ApproachesSemantic proximity Read ↗

Pheochromocytoma and paraganglioma: molecular testing and personalized medicine.Semantic proximity Read ↗

Genetic bases of pheochromocytoma and paraganglioma.Semantic proximity Read ↗

Familial pheochromocytomas and paragangliomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.